Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents Lexaria Bioscience (LEXX): Bringing Vitamin Delivery to the Next Level

Host Carmel Fisher interviews CEO Chris Bunka on Lexaria’s advancement in creating a superior absorption system for fat soluble nutrients.

Biotechnology
Healthcare
September 19, 2022

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: BioHarvest Sciences (BHST) – Global Leader in Plant Cell Technology December 03, 2024
Sequire Spotlight Presents: Biostem (BSEM) – Harnessing the Natural Properties of Placenta Tissues November 20, 2024
Sequire Spotlight Presents: Ederra – World-First Farm-to-Body Functional Superfood Supplement November 19, 2024
Sequire Spotlight Presents: OS Therapies (OSTX) – Creating Pharma Technology for Children with Cancer November 12, 2024
Sequire Spotlight Presents: NRX Pharmaceuticals Inc (NRXP) – Bringing Hope to Life July 01, 2024
Sequire Spotlight Presents: AnixaBiosciences – Immunotherapy to Prevent Cancer June 28, 2024
Sequire Spotlight Presents Tharimmune (THAR): Solving Problems for Patients with Liver Diseases June 20, 2024
Sequire Spotlight Presents: Navigating Health Insurance with GoHealth, Inc. (GOCO) April 02, 2024
Sequire Spotlight Presents IGC Pharma (IGC): A Focus on Alzheimer’s Molecules August 22, 2023
Sequire Spotlight Presents Aethlon (AEMD): A Clinical Stage Medical Device Company August 22, 2023

Related Post

Pacaso — The $1.3 Trillion Secret That Everyday Investors Are Finally Invited To

May 6, 2025
OS Therapies FDA Meeting Request Granted

April 22, 2025
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans

April 10, 2025
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline

January 29, 2025

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.